SteelSky Ventures

SteelSky Ventures is a female-led venture capital firm dedicated to enhancing women's healthcare by investing in companies that improve access, care, and outcomes. The firm focuses on early-stage investments across various sectors, including medical devices, digital health, consumer health, e-pharmacy, and retail therapeutics. SteelSky Ventures aims to address the significant underfunding in women's health by supporting innovative solutions that cater to the unique needs of women.

The firm's investment strategy emphasizes sectors such as medical devices, digital health, consumer health, e-pharmacy, and retail therapeutics, targeting companies that offer innovative solutions to improve women's health. SteelSky Ventures is committed to fostering diversity and inclusion within the healthcare industry, aiming to create a more equitable landscape for women's health.

SteelSky Ventures has made notable investments in companies like Raydiant Oximetry, which developed a non-invasive sensor to monitor fetal oxygenation during labor, and Twentyeight Health, a telemedicine platform providing affordable reproductive healthcare services. These investments reflect the firm's dedication to supporting innovative solutions that address critical challenges in women's healthcare.